ZETADENT Trademark

Trademark Overview

On Monday, April 18, 2022, a trademark application was filed for ZETADENT with the United States Patent and Trademark Office. The USPTO has given the ZETADENT trademark a serial number of 97367624. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, August 21, 2024. This trademark is owned by Zetagen Therapeutics, Inc.. The ZETADENT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of bone diseases
zetadent

General Information

Serial Number97367624
Word MarkZETADENT
Filing DateMonday, April 18, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, August 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2022

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of bone diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZetagen Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSyracuse, NY 13210
Party NameZetagen Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSyracuse, NY 13210

Trademark Events

Event DateEvent Description
Thursday, April 21, 2022NEW APPLICATION ENTERED
Thursday, June 30, 2022ASSIGNED TO EXAMINER
Thursday, June 30, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 22, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 2, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 2, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 13, 2023SOU EXTENSION 1 FILED
Monday, March 13, 2023SOU TEAS EXTENSION RECEIVED
Monday, March 13, 2023SOU EXTENSION 1 GRANTED
Wednesday, March 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 14, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 7, 2023ASSIGNED TO EXAMINER
Tuesday, February 20, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 20, 2024SOU EXTENSION 3 FILED
Wednesday, February 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 14, 2023SOU EXTENSION 2 FILED
Thursday, September 14, 2023SOU EXTENSION 2 GRANTED
Saturday, September 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 20, 2024SOU EXTENSION 3 GRANTED
Wednesday, August 21, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 21, 2024SOU EXTENSION 4 FILED
Wednesday, August 21, 2024SOU EXTENSION 4 GRANTED

Related Keywords

zetadent diseases bone treatment products pharmaceutical